Price$18.99+10.34 (+119.54%)
2025-07-172025-10-17
Latest news
25 items- SECAmendment: SEC Form SCHEDULE 13G/A filed by ZimVie Inc.SCHEDULE 13G/A - ZimVie Inc. (0001876588) (Subject)
- SECAmendment: SEC Form SCHEDULE 13G/A filed by ZimVie Inc.SCHEDULE 13G/A - ZimVie Inc. (0001876588) (Subject)
- SECSEC Form 15-12G filed by ZimVie Inc.15-12G - ZimVie Inc. (0001876588) (Filer)
- SECAmendment: SEC Form SCHEDULE 13D/A filed by ZimVie Inc.SCHEDULE 13D/A - ZimVie Inc. (0001876588) (Subject)
- SECAmendment: SEC Form 25-NSE/A filed by ZimVie Inc.25-NSE/A - ZimVie Inc. (0001876588) (Subject)
- INSIDEROfficer Kanaglekar Indraneel returned 63,438 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - ZimVie Inc. (0001876588) (Issuer)
- INSIDERDirector Crawford Sally returned 40,127 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - ZimVie Inc. (0001876588) (Issuer)
- INSIDEROfficer Schneider Sandra returned 40,794 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - ZimVie Inc. (0001876588) (Issuer)
- INSIDERSEC Form 4 filed by Director Asar Vinit K4 - ZimVie Inc. (0001876588) (Issuer)
- INSIDEROfficer Kidwell Heather returned 83,674 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - ZimVie Inc. (0001876588) (Issuer)
- INSIDEROfficer Jamali Vafa returned 389,152 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - ZimVie Inc. (0001876588) (Issuer)
- INSIDERSEC Form 4 filed by Director Kuntz Richard4 - ZimVie Inc. (0001876588) (Issuer)
- INSIDERSEC Form 4 filed by Director Matusinec Karen4 - ZimVie Inc. (0001876588) (Issuer)
- INSIDEROfficer Heppenstall Richard returned 125,389 shares to the company, closing all direct ownership in the company (SEC Form 4)4 - ZimVie Inc. (0001876588) (Issuer)
- SECSEC Form S-8 POS filed by ZimVie Inc.S-8 POS - ZimVie Inc. (0001876588) (Filer)
- SECSEC Form S-8 POS filed by ZimVie Inc.S-8 POS - ZimVie Inc. (0001876588) (Filer)
- SECSEC Form S-8 POS filed by ZimVie Inc.S-8 POS - ZimVie Inc. (0001876588) (Filer)
- SECSEC Form 25-NSE filed by ZimVie Inc.25-NSE - ZimVie Inc. (0001876588) (Subject)
- SECSEC Form 8-K filed by ZimVie Inc.8-K - ZimVie Inc. (0001876588) (Filer)
- PRZimVie Announces Completion of its Acquisition by ARCHIMEDPALM BEACH GARDENS, Fla., Oct. 20, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. ("ZimVie"), a global life sciences leader in the dental implant market, today announced that ARCHIMED, an investment firm focused exclusively on healthcare industries, has completed its previously announced acquisition of ZimVie. Pursuant to the terms of the transaction announced on July 20, 2025, ARCHIMED acquired all of the outstanding shares of ZimVie stock. ZimVie stockholders are entitled to receive $19.00 in cash for each share of ZimVie common stock owned. As a result of the transaction completion, ZimVie's common stock no longer trades on the NASDAQ stock exchange. "We are excited to partner with ZimVie to ac
- SECSEC Form 8-K filed by ZimVie Inc.8-K - ZimVie Inc. (0001876588) (Filer)
- PRZimVie Stockholders Vote to Approve Acquisition by ARCHIMEDPALM BEACH GARDENS, Fla., Oct. 10, 2025 (GLOBE NEWSWIRE) -- ZimVie Inc. ("ZimVie") (NASDAQ:ZIMV) today announced that at the special meeting of ZimVie stockholders held on October 10, 2025, the ZimVie stockholders voted to approve the acquisition of ZimVie by an affiliate of ARCHIMED (the "Merger") pursuant to the terms and conditions of the Agreement and Plan of Merger, dated as of July 20, 2025 (the "Merger Agreement"). The parties now expect the Merger to close on October 20, 2025, subject to the satisfaction of all conditions in the Merger Agreement. About ZimVie ZimVie is a global life sciences leader in the dental implant market that develops, manufactures, and delivers a comprehe
- SECSEC Form DEFA14A filed by ZimVie Inc.DEFA14A - ZimVie Inc. (0001876588) (Filer)
- SECSEC Form DEFA14A filed by ZimVie Inc.DEFA14A - ZimVie Inc. (0001876588) (Filer)
- SECSEC Form 8-K filed by ZimVie Inc.8-K - ZimVie Inc. (0001876588) (Filer)
ZIMV FAQ
6 questionsWhat does ZimVie Inc. do?
ZimVie Inc., a medical technology company, develops, manufactures, and delivers a portfolio of products and solutions designed to treat a range of spine pathologies, and support dental tooth replacement and restoration procedures worldwide. It offers dental implant systems, prosthetic and abutment products, surgical instrumentation, and kits; bone grafts, barrier membranes, allografts, and collagen wound care products; intraoral scanners; and virtual treatment planning services, guided surgery solutions, CAD/CAM workflow systems, and patient-specific restorative components and intra-oral...Where does ZIMV stock trade?
ZimVie Inc. (ZIMV) is listed on NASDAQ.What sector and industry is ZIMV in?
ZimVie Inc. operates in the Health Care sector, Medical/Dental Instruments industry.What are analysts saying about ZIMV?
ZimVie Inc. has had 8 recent analyst actions on file. The most recent action was from B. Riley Securities: Neutral with a $1900.00 price target on 2025-07-31. Recent price targets range from $900.00 to $2000.00.What companies are similar to ZIMV?
Notable peers in the same industry include SYK (Stryker Corporation), MMM (3M Company), BSX (Boston Scientific Corporation), MDLN (Medline Inc.), BDX (Becton Dickinson and Company). Compare ZIMV side-by-side with any of them on Quantisnow.How can I track ZIMV on Quantisnow?
Quantisnow aggregates ZimVie Inc.'s SEC filings, analyst ratings, insider transactions, FDA approvals, and press releases the moment they hit the wire (Wall Street's wire, on your screen.). Follow ZIMV to receive live email and push alerts on every new disclosure.